Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies

被引:60
作者
Bonferoni, MC
Chetoni, P
Giunchedi, P
Rossi, S
Ferrari, F
Burgalassi, S
Caramella, C
机构
[1] Dept Pharmaceut Chem, I-27100 Pavia, Italy
[2] Dept Bioorgan Chem & Biopharmaceut, Pisa, Italy
[3] Dept Pharmaceut Sci, Sassari, Italy
关键词
ophthalmic delivery; mucoadhesion; lambda-carrageenan; gelatin; ionic interaction;
D O I
10.1016/j.ejpb.2003.12.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
dLambda-carrageenan is an anionic polymer able to ionically interact with alkaline drugs. This results in a complex that releases the drug slowly, due to displacement by the counterions of the release medium. The aim of this work was to assess the possible ophthalmic employment of such a complex. As a model drug, an alkaline anti-glaucoma drug, timolol maleate, was chosen. Systems in which lambda-carrageenan interacted both with the drug and a mucoadhesive polymer such as gelatin were studied. The combination of carrageenan and gelatin in different ratios proved to be useful in modulating the drug release profiles, the rheological properties of the hydrated formulations and their mucoadhesive properties. Both films and microspheres were prepared and tested in vitro. A microsphere formulation was also tested in vivo in albino rabbits. The drug concentration and bioavailability in the aqueous humour were significantly high in comparison with commercial formulations. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:465 / 472
页数:8
相关论文
共 19 条
  • [1] ALBASINI M, 1995, FARMACO, V50, P633
  • [2] A modified Franz diffusion cell for simultaneous assessment of drug release and washability of mucoadhesive gels
    Bonferoni, MC
    Rossi, S
    Ferrari, F
    Caramella, C
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 1999, 4 (01) : 45 - 53
  • [3] BOTTARI F, 1978, FARM ED PRAT, V33, P434
  • [4] Burgalassi S, 1996, EUR J PHARM BIOPHARM, V42, P385
  • [5] Xyloglucan as a novel vehicle for timolol: Pharmacokinetics and pressure lowering activity in rabbits
    Burgalassi, S
    Chetoni, P
    Panichi, L
    Boldrini, E
    Saettone, MF
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2000, 16 (06) : 497 - 509
  • [6] CARAMELLA C, 2002, Patent No. 6355272
  • [7] PILOCARPINE BIOAVAILABILITY FROM A MUCOADHESIVE LIPOSOMAL OPHTHALMIC DRUG DELIVERY SYSTEM
    DURRANI, AM
    DAVIES, NM
    THOMAS, M
    KELLAWAY, IW
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 88 (1-3) : 409 - 415
  • [8] Comparative rheomechanical and adhesive properties of two hydrocolloid dressings: Dependence on the degree of hydration
    Ferrari, F
    Bertoni, M
    Rossi, S
    Bonferoni, MC
    Caramella, C
    Waring, MJ
    Aulton, ME
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (12) : 1223 - 1230
  • [9] Ferrari F., 1995, INT J PHARM ADV, V1, P27
  • [10] Pectin microspheres as ophthalmic carriers for piroxicam: evaluation in vitro and in vivo in albino rabbits
    Giunchedi, P
    Conte, U
    Chetoni, P
    Saettone, MF
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 9 (01) : 1 - 7